Research & Development

🚀 At BioLink Therapeutics, Science Meets Purpose. Innovation Meets Urgency.

At BioLink Therapeutics, we are advancing a bold, global vision: to accelerate the discovery of AI-powered small-molecule therapeutics targeting antimicrobial resistance (AMR) and neurodegenerative diseases—two of the most urgent and underserved challenges in medicine today.

At the same time, we are in the process of licensing next-generation, affordable point-of-care (POC) cancer screening technology from a U.S.-based startup to make early detection kits more accessible in India and other resource-limited regions.

🌍 What sets us apart?

We are a global team of scientists from the U.S., Europe, and India, united by a mission to deliver breakthrough, cost-effective healthcare solutions to populations that need them the most.

🔬 Powered by AI-powered cutting-edge science

🤝 Backed by international expertise

🌱 Ready to scale impact

We are excited to announce that we are about to incubate with one of India’s top biotech accelerators, a hub for high-impact innovation.

We are now actively seeking seed funding to:
✅ Launch first-in-India clinical trials
✅ Drive regulatory approvals

✅ Advance our dual pipeline in AMR and neurodegeneration

💡 If you are a VC passionate about transformative, purpose-driven biotech, we invite you to partner with us.

Let’s reshape global health—together.

#BioLinkTherapeutics #VCFunding #GlobalHealth #AntimicrobialResistance #Neurodegeneration #CancerScreening #BiotechInnovation #SeedFunding #HealthcareEquity #StartupsForGood #OneHealth #IndiaInnovation